^{Genomics and Molecular Biology}

Alex Chenchik is the President and Scientifi c Director of Cellecta Inc., Mountain View, California, USA. His work focuses on “Development and application of next generation functional genomic technologies for discovery biomarkers, drug targets and development novel drugs”. He worked for Systems Biosciences, LLC as Vice- President of R/D and developed genetic screen technology with pooled lentiviral shRNA libraries in combination with a wide range of reporter cell lines. He also worked for BDB Clontech as Director of GCA Department and participated in the development of microarrays and disease-profi ling arrays for expression profi ling, PCR-based technologies for gene cloning, and subtraction-based approach for discovery of differentially expressed genes. He has done PhD in Molecular Biology (1982) from Institute of Molecular Biology, Moscow, Russia. He did MS in Chemistry (1978) at Institute of Fine Chemical Technology, Moscow, Russia.